Table 1 Clinical information on the discovery and validation plasma sample cohorts
From: Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression
Discovery Cohort | ||
|---|---|---|
| Â | n (M/F) | Age |
Normal | 8 (4/4) | 67 ± 11 |
Polyps | 8 (4/4) | 65 ± 7 |
Adenoma | 16 (8/8) | 56 ± 6 |
Early Stage Cancer (Stage I/II) | 8 (4/4) | 65 ± 10 |
Advanced Cancer (Stage III/IV) | 8 (4/4) | 68 ± 8 |
Validation Cohort | ||
| Â | n (M/F) | Age |
Normal | 20 (12/8) | 63 ± 8 |
Polyps | 20 (11/9) | 57 ± 7 |
Adenoma | 20 (12/8) | 62 ± 10 |
Early Stage Cancer (Stage I/II) | 23 (10/13) | 63 ± 12 |
Advanced Cancer (Stage III/IV) | 14 (9/5) | 67 ± 8 |